Management of Severe Transaminase Elevation (ALT/AST > 400 IU/L)

Immediate Therapeutic Actions

Discontinue all potentially hepatotoxic agents immediately (prescription, over‑the‑counter, herbal, and dietary supplements) when transaminases exceed 400 IU/L. 1
Start N‑acetylcysteine (NAC) without waiting for acetaminophen levels; NAC improves transplant‑free survival (41 % vs 30 %, p = 0.01) and post‑transplant survival (85.7 % vs 71.4 %, p = 0.03) in acute liver failure of any cause. 1
For acetaminophen‑related injury, NAC further reduces progression to severe encephalopathy (51 % vs 75 %, p < 0.05) and mortality (37 % vs 63 %, p < 0.05). 1

Obtain a comprehensive liver panel (ALT, AST, alkaline phosphatase, GGT, bilirubin fractions, albumin, INR) to define injury pattern and synthetic function. 1
Calculate the R‑value to classify injury: R ≥ 5 = hepatocellular, R ≤ 2 = cholestatic, 2 < R < 5 = mixed. 1
Perform viral hepatitis serologies (HAV IgM, HBsAg, HBc IgM, HCV antibody) promptly, as acute viral hepatitis is a frequent cause of severe transaminase rise. 1
Screen for acetaminophen exposure (serum level) even when the history is unclear, because acetaminophen toxicity accounts for 22 % of severe acute liver failure cases. 1
Conduct abdominal Doppler ultrasound to rule out chronic liver disease, assess hepatic and portal vein patency, and detect biliary obstruction. 1
Order echocardiography when ischemic (hypoxic) hepatitis is suspected, especially in patients with recent hypotension, cardiac events, or arrhythmias. 1

Acetaminophen overdose is the leading cause of severe acute liver failure requiring emergency transplantation. 1
Ischemic (hypoxic) hepatitis occurs in critically ill patients with cardiac or circulatory failure and typically shows AST > ALT. 1
Acute viral hepatitis (A, B, or E) commonly presents with ALT/AST > 400 IU/L and mandates serologic confirmation. 1
Drug‑induced liver injury from antimicrobials, antiepileptics, or statins contributes to ≈ 9.4 % of acute liver failure cases. 1
Toxic exposures (herbal supplements, cocaine, ecstasy, poisonous mushrooms) should be queried in the history. 1

Signs of hepatic decompensation (encephalopathy, INR > 2, jaundice, ascites) indicate progression to acute liver failure and trigger urgent hepatology consultation. 1
Cerebral edema develops in 40–68 % of acetaminophen‑related acute liver failure, underscoring the need for neuro‑monitoring. 1
Transplant‑free survival varies by cause: acetaminophen, hepatitis A, hypoxic hepatitis, and pregnancy‑related injury have ~50 % survival; hepatitis B, non‑acetaminophen drugs, autoimmune hepatitis, and Wilson disease have <25 % survival without transplantation. 1

Refer to a transplant center immediately if any of the following appear: INR > 2, bilirubin > 2 × upper‑limit‑of‑normal, or any grade of encephalopathy. 1

Do not rule out acetaminophen toxicity without serum testing; many patients are unaware of ingested acetaminophen. 1
Do not delay NAC while awaiting acetaminophen levels; early administration improves outcomes across etiologies. 1
Do not overlook ischemic hepatitis in elderly or critically ill patients with cardiac dysfunction; obtain echocardiography and address circulatory failure promptly. 1
Recognize that in ~25 % of acute liver failure cases the cause remains unknown; nevertheless, aggressive supportive care and transplant evaluation are required. 1